NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT03143153,A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin,https://clinicaltrials.gov/study/NCT03143153,CheckMate 648,COMPLETED,The main purpose of this study is to compare how long subjects with esophageal cancer live overall or live without disease progression after receiving nivolumab and ipilimumab or nivolumab combined with fluorouracil plus cisplatin versus fluorouracil plus cisplatin,YES,Various Advanced Cancer,BIOLOGICAL: Nivolumab|BIOLOGICAL: Ipilimumab|DRUG: Cisplatin|DRUG: Fluorouracil,"Overall Survival (OS) in Participants With Tumor Cell PD-L1, Overall Survival (OS) is defined as the time between the date of randomization and the date of death. For participants without documentation of death, OS will be censored on the last date the subject was known to be alive., From the date of randomization to up to the date of death (up to approximately 20 months)|Progression-free Survival (PFS) as Assessed by BICR in Participants With Tumor Cell PD-L1, Progression-free survival (PFS) is defined as the time from randomization to the date of the first documented progressive disease (PD) per Blinded Independent Central Review (BICR) or death due to any cause. Participants who die without a reported prior PD per BICR (and die without start of subsequent therapy) will be considered to have progressed on the date of death. Participants who did not have documented PD per BICR per RECIST1.1 criteria and who did not die, will be censored at the date of the last evaluable tumor assessment on or prior to initiation of the subsequent anti-cancer therapy. Participants who did not have any on-study tumor assessments and did not die (or died after initiation of the subsequent anti-cancer therapy) will be censored at the randomization date. Participants who started any subsequent anti-cancer therapy without a prior reported PD per BICR will be censored at the last tumor assessment on or prior to initiation of the subsequent anti-cancer therapy., From the date of randomization to up to the date of the first documented disease progression or death (up to approximately 9 months)","Overall Survival (OS) in All Randomized Participants, Overall Survival (OS) is defined as the time between the date of randomization and the date of death. For participants without documentation of death, OS will be censored on the last date the subject was known to be alive., From the date of randomization to up to the date of death (up to approximately 16 months)|Progression-free Survival (PFS) in All Randomized Participants as Assessed by BICR, Progression-free survival (PFS) is defined as the time from randomization to the date of the first documented progressive disease (PD) per Blinded Independent Central Review (BICR) or death due to any cause. Participants who die without a reported prior PD per BICR (and die without start of subsequent therapy) will be considered to have progressed on the date of death. Participants who did not have documented PD per BICR per RECIST1.1 criteria and who did not die, will be censored at the date of the last evaluable tumor assessment on or prior to initiation of the subsequent anti-cancer therapy. Participants who did not have any on-study tumor assessments and did not die (or died after initiation of the subsequent anti-cancer therapy) will be censored at the randomization date. Participants who started any subsequent anti-cancer therapy without a prior reported PD per BICR will be censored at the last tumor assessment on or prior to initiation of the subsequent anti-cancer therapy., From the date of randomization to up to the date of the first documented disease progression or death (up to approximately 7 months)|Objective Response Rate (ORR) as Assessed by BICR, Objective response rate (ORR) is defined as the percentage of participants with a best overall response (BOR) of complete response (CR) or partial response (PR). Best overall response (BOR) is defined as the best response designation as determined by BICR, recorded between the date of randomization and the date of objectively documented progression (per RECIST 1.1) or the date of subsequent anti-cancer therapy (including tumor-directed radiotherapy and tumor-directed surgery), whichever occurs first. Partial response is defined as at least a 30% decrease in the sum of diameters of target lesions. Complete response is defined as the disappearance of all target lesions and the reduction of any pathological lymph nodes to \<10 mm., From the date of randomization to up to the date of objectively documented progression or the date of subsequent anti-cancer therapy, whichever occurs first (up to 40 months)",,Bristol-Myers Squibb,Ono Pharmaceutical Co. Ltd,ALL,"ADULT, OLDER_ADULT",PHASE3,970,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CA209-648|2016-001514-20,2017-06-29,2021-01-18,2025-01-13,2017-05-08,2022-03-02,2025-03-25,"Local Institution - 0191, Mobile, Alabama, 36608, United States|Arizona Cancer Center, Tucson, Arizona, 85724, United States|Usc/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Local Institution - 0188, Denver, Colorado, 80218, United States|University Of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Local Institution - 0186, Miami, Florida, 33176, United States|Local Institution - 0225, Tampa, Florida, 33612, United States|Local Institution - 0074, Atlanta, Georgia, 30322, United States|Local Institution - 0032, Marietta, Georgia, 30060, United States|Hackensack Meridian Jersey Shore University Medical Center, Neptune, New Jersey, 07753, United States|Oncology Associates Of Oregon, Pc, Eugene, Oregon, 97401, United States|Northwest Cancer Specialists, P.C., Portland, Oregon, 97227, United States|Local Institution - 0210, Dallas, Texas, 75246, United States|Local Institution - 0028, Houston, Texas, 77030, United States|Local Institution - 0190, Roanoke, Virginia, 24014, United States|Local Institution - 0203, Morgantown, West Virginia, 26506-9162, United States|Local Institution - 0050, Capital Federal, Buenos Aires, 1264, Argentina|Local Institution - 0086, Rosario, Santa FE, 2000, Argentina|Local Institution - 0048, Buenos Aires, 1417, Argentina|Local Institution - 0087, La Rioja, 5300, Argentina|Local Institution - 0232, Tamworth, New South Wales, 2340, Australia|Local Institution - 0011, Douglas, Queensland, 4814, Australia|Local Institution - 0010, Murdoch, Western Australia, 6150, Australia|Local Institution - 0241, Salzburg, 5020, Austria|Local Institution - 0017, Salvador, Bahia, 41950-640, Brazil|Local Institution - 0227, Ipatinga, Minas Gerais, 35160-158, Brazil|Local Institution - 0021, Ijui, RIO Grande DO SUL, 98700-000, Brazil|Local Institution - 0016, Porto Alegre, RIO Grande DO SUL, 90610-000, Brazil|Local Institution - 0019, Barretos, Sao Paulo, 14780-070, Brazil|Local Institution - 0226, Jau, Sao Paulo, 17210-080, Brazil|Local Institution - 0018, São José do Rio Preto, São Paulo, 15090000, Brazil|Local Institution - 0228, Rio de Janeiro, 22793-080, Brazil|Local Institution - 0020, Sao Paulo, 01246-000, Brazil|Local Institution - 0095, Moncton, New Brunswick, E1C 6Z8, Canada|Local Institution - 0082, Montreal, Quebec, H3T 1E2, Canada|Local Institution - 0222, Montreal, Quebec, H4A 3J1, Canada|Local Institution - 0037, Trois-Rivieres, Quebec, G8Z 3R9, Canada|Local Institution - 0053, Santiago, Metropolitana, 8320000, Chile|Local Institution - 0214, Santiago, Metropolitana, Chile|Local Institution - 0207, Hefei, Anhui, 230022, China|Local Institution - 0197, Hefei, Anhui, 230061, China|Local Institution - 0182, Beijing, Beijing, 100032, China|Local Institution - 0179, Beijing, Beijing, 100071, China|Local Institution - 0216, Beijing, Beijing, 100853, China|Local Institution - 0217, Fuzhou, Fujian, 350014, China|Local Institution - 0219, Fuzhou, Fujian, 350025, China|Local Institution - 0199, Shantou, Guangdong, 515041, China|Local Institution - 0185, Harbin, Heilongjiang, 155040, China|Local Institution - 0193, Zhengzhou, Henan, 0, China|Local Institution - 0195, Zhengzhou, Henan, 450008, China|Local Institution - 0194, Zhengzhou, Henan, 450052, China|Local Institution - 0249, Changsha, Hunan, 410000, China|Local Institution - 0212, Changsha, Hunan, 410008, China|Local Institution - 0201, Nanjing, Jiangsu, 210000, China|Local Institution - 0180, Changchun, Jilin, 130021, China|Local Institution - 0183, Xi'an, Shan3xi, 710038, China|Local Institution - 0215, Shanghai, Shanghai, 200030, China|Local Institution - 0200, Shanghai, Shanghai, 200032, China|Local Institution - 0184, Hangzhou, Zhejiang, 310003, China|Local Institution - 0247, Linhai, Zhejiang, 317000, China|Local Institution - 0220, Shenyang, 110042, China|Local Institution - 0248, Xi'An, 0, China|Local Institution - 0059, Bogota, 0, Colombia|Local Institution - 0058, Medellin, 050034, Colombia|Local Institution - 0224, Monteria, 230001, Colombia|Local Institution - 0094, Pereira, 660004, Colombia|Local Institution - 0083, Brno, 625 00, Czechia|Local Institution - 0008, Brno, 656 53, Czechia|Local Institution - 0006, Novy Jicin, 741 01, Czechia|Local Institution - 0099, Odense, 5000, Denmark|Local Institution - 0116, Lille, Nord, 59000, France|Local Institution - 0114, Caen, 14076, France|Local Institution - 0112, Montpellier, 34090, France|Local Institution - 0113, Rennes Cedex, 35042, France|Local Institution - 0242, Toulouse, 31059, France|Local Institution - 0115, Villejuif, 94800, France|Local Institution - 0035, Hong Kong, 0, Hong Kong|Local Institution - 0070, Kowloon, Hong Kong|Local Institution - 0085, Bergamo, 24127, Italy|Local Institution - 0039, Milano, 20133, Italy|Local Institution - 0084, Padova, Padova, Italy|Local Institution - 0240, Pisa, 56126, Italy|Local Institution - 0152, Akita-shi, Akita, 010-8543, Japan|Local Institution - 0104, Hirosaki-shi, Aomori, 0368563, Japan|Local Institution - 0173, Kashiwa-shi, Chiba, 2778577, Japan|Local Institution - 0169, Matsuyama-shi, Ehime, 7900024, Japan|Local Institution - 0119, Matsuyama-shi, Ehime, 7910280, Japan|Local Institution - 0174, Fukuoka-shi, Fukuoka, 8111395, Japan|Local Institution - 0142, Fukuoka-shi, Fukuoka, 8128582, Japan|Local Institution - 0103, Fukushima-shi, Fukushima, 9601295, Japan|Local Institution - 0154, Gifu City, Gifu, 5011194, Japan|Local Institution - 0176, Ota, Gunma, 3738550, Japan|Local Institution - 0100, Hiroshima-Shi, Hiroshima, 7348551, Japan|Local Institution - 0111, Sapporo-shi, Hokkaido, 060-8648, Japan|Local Institution - 0170, Akashi-shi, Hyogo, 6738558, Japan|Local Institution - 0118, Kobe-shi, Hyogo, 6500047, Japan|Local Institution - 0172, Kobe, Hyogo, 6500017, Japan|Local Institution - 0171, Kanazawa, Ishikawa, 920-8530, Japan|Local Institution - 0229, Kagoshima-shi, Kagoshima, 8908520, Japan|Local Institution - 0127, Isehara, Kanagawa, 259-1193, Japan|Local Institution - 0109, Kawasaki-shi, Kanagawa, 216-8511, Japan|Local Institution - 0105, Sagamihara-shi, Kanagawa, 2520375, Japan|Local Institution - 0147, Yokohama-shi, Kanagawa, 2360004, Japan|Local Institution - 0117, Yokohama-shi, Kanagawa, 2418515, Japan|Local Institution - 0141, Kumamoto-shi, Kumamoto, 8608556, Japan|Local Institution - 0120, Kamigyo-ku, Kyoto, 602-8566, Japan|Local Institution - 0144, Sendai, Miyagi, 9808575, Japan|Local Institution - 0146, Niigata-shi, Niigata, 9518566, Japan|Local Institution - 0135, Kurashiki-shi, Okayama, 7010192, Japan|Local Institution - 0137, Okayama-shi, Okayama, 7008558, Japan|Local Institution - 0221, Hirakata, Osaka, 573-1191, Japan|Local Institution - 0138, Osaka-shi, Osaka, 5418567, Japan|Local Institution - 0098, Osakasayama, Osaka, 589-8511, Japan|Local Institution - 0107, Suita, Osaka, 5650871, Japan|Local Institution - 0139, Takatsuki City, Osaka, 569-8686, Japan|Local Institution - 0230, Hidaka-shi, Saitama, 3501298, Japan|Local Institution - 0175, Kitaadachi-gun, Saitama, 3620806, Japan|Local Institution - 0143, Sunto-gun, Shizuoka, 411-8777, Japan|Local Institution - 0148, Shimotsuga-gun, Tochigi, 321-0293, Japan|Local Institution - 0106, Bunkyo-ku, Tokyo, 1138519, Japan|Local Institution - 0110, Bunkyo-ku, Tokyo, 1138677, Japan|Local Institution - 0136, Chuo-ku, Tokyo, 1040045, Japan|Local Institution - 0128, Chuo-ku, Tokyo, 1048560, Japan|Local Institution - 0126, Koto-ku, Tokyo, 1358550, Japan|Local Institution - 0156, Minato-ku, Tokyo, 1058470, Japan|Local Institution - 0245, Ota-ku, Tokyo, 1438541, Japan|Local Institution - 0140, Shinagawa-ku, Tokyo, 142-8666, Japan|Local Institution - 0196, Shinjuku-Ku, Tokyo, 1608582, Japan|Local Institution - 0155, Shinjuku-ku, Tokyo, 1628666, Japan|Local Institution - 0231, Toyama-shi, Toyama, 9300194, Japan|Local Institution - 0178, Wakayama-shi, Wakayama, 641-8510, Japan|Local Institution - 0238, Ube-shi, Yamaguchi, 7558505, Japan|Local Institution - 0101, Chiba, 260-8717, Japan|Local Institution - 0153, Chiba, 2608670, Japan|Local Institution - 0145, Kyoto, 606-8507, Japan|Local Institution - 0108, Shizuoka, 4208527, Japan|Local Institution - 0129, Seongnam-si, Kyǒnggi-do, 13620, Korea, Republic of|Local Institution - 0165, Seoul, Seoul-teukbyeolsi [Seoul], 02841, Korea, Republic of|Local Institution - 0166, Busan, 49241, Korea, Republic of|Local Institution - 0150, Daegu, 41404, Korea, Republic of|Local Institution - 0149, Daejeon, 35015, Korea, Republic of|Local Institution - 0236, Jeonju-si, 54907, Korea, Republic of|Local Institution - 0235, Seoul, 01812, Korea, Republic of|Local Institution - 0130, Seoul, 05505, Korea, Republic of|Local Institution - 0177, Seoul, 06351, Korea, Republic of|Local Institution - 0168, Seoul, 06591, Korea, Republic of|Local Institution - 0151, Seoul, 07345, Korea, Republic of|Local Institution - 0131, Seoul, 08308, Korea, Republic of|Local Institution - 0123, Seoul, 120-752, Korea, Republic of|Local Institution - 0157, Ulsan, 44033, Korea, Republic of|Local Institution - 0090, Tuxtla Gutierrez, Chiapas, 29038, Mexico|Local Institution - 0102, Mexico, Distrito Federal, 14000, Mexico|Local Institution - 0071, Merida, Yucatan, 97138, Mexico|Local Institution - 0234, San Luis Potosi, 78200, Mexico|Local Institution - 0092, Callao, 02, Peru|Local Institution - 0060, Lima, 34, Peru|Local Institution - 0093, Lima, Lima 11, Peru|Local Institution - 0024, Lublin, 20-081, Poland|Local Institution - 0022, Warszawa, 02-781, Poland|Local Institution - 0243, Porto, 4200-072, Portugal|Local Institution - 0081, Bucuresti, 021389, Romania|Local Institution - 0079, Cluj-Napoca, 400015, Romania|Local Institution - 0076, Craiova, 200347, Romania|Local Institution - 0080, Suceava, 720237, Romania|Local Institution - 0089, Moscow, 121309, Russian Federation|Local Institution - 0088, St Petersburg, 198255, Russian Federation|Local Institution - 0033, Singapore, Central Singapore, 168583, Singapore|Local Institution - 0034, Singapore, 119228, Singapore|Local Institution - 0063, Barcelona, 08035, Spain|Local Institution - 0062, Madrid, 28050, Spain|Local Institution - 0158, Changhua County, Changhua, 50006, Taiwan|Local Institution - 0161, Tainan, TNN, 704, Taiwan|Local Institution - 0163, Kaohsiung County, 0, Taiwan|Local Institution - 0167, Kaohsiung, 807, Taiwan|Local Institution - 0133, Kaohsiung, 833, Taiwan|Local Institution - 0164, Keelung, 204, Taiwan|Local Institution - 0132, Taichung, 40447, Taiwan|Local Institution - 0160, Tainan, 71004, Taiwan|Local Institution - 0124, Taipei, 100, Taiwan|Local Institution - 0162, Taipei, 10449, Taiwan|Local Institution - 0134, Taipei, 11217, Taiwan|Local Institution - 0159, Taoyuan, 333, Taiwan|Local Institution - 0096, Ankara, 06100, Turkey|Local Institution - 0125, Diyarbakır, 21280, Turkey|Local Institution - 0122, Edrine, 22010, Turkey|Local Institution - 0069, London, Greater London, NW1 2PG, United Kingdom|Local Institution - 0066, London, Greater London, SW3 6JJ, United Kingdom|Local Institution - 0031, Manchester, Greater Manchester, M20 4BX, United Kingdom|Local Institution - 0237, London, EC1A 7BE, United Kingdom|Local Institution - 0029, Surrey, SM2 5PT, United Kingdom","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/53/NCT03143153/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/53/NCT03143153/SAP_001.pdf"
